Enliven Therapeutics shares owned by Legato Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Legato Capital Management
from 13F filings
Historical chart of Legato Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Legato Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $372k | 15k | 25.54 |